NO933742L - Humant, benavledet, insulinlignende vekstfaktorbindingsprotein - Google Patents

Humant, benavledet, insulinlignende vekstfaktorbindingsprotein

Info

Publication number
NO933742L
NO933742L NO933742A NO933742A NO933742L NO 933742 L NO933742 L NO 933742L NO 933742 A NO933742 A NO 933742A NO 933742 A NO933742 A NO 933742A NO 933742 L NO933742 L NO 933742L
Authority
NO
Norway
Prior art keywords
binding protein
insulin
human
igf
bone
Prior art date
Application number
NO933742A
Other languages
English (en)
Norwegian (no)
Inventor
Subburaman Mohan
David J Baylink
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of NO933742L publication Critical patent/NO933742L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4743—Insulin-like growth factor binding protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO933742A 1991-04-19 1993-10-18 Humant, benavledet, insulinlignende vekstfaktorbindingsprotein NO933742L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68835391A 1991-04-19 1991-04-19

Publications (1)

Publication Number Publication Date
NO933742L true NO933742L (no) 1993-10-18

Family

ID=24764088

Family Applications (1)

Application Number Title Priority Date Filing Date
NO933742A NO933742L (no) 1991-04-19 1993-10-18 Humant, benavledet, insulinlignende vekstfaktorbindingsprotein

Country Status (11)

Country Link
EP (1) EP0580752A4 (cs)
JP (1) JP2527896B2 (cs)
KR (1) KR0129864B1 (cs)
AU (1) AU658187B2 (cs)
CA (1) CA2107475A1 (cs)
CZ (1) CZ283601B6 (cs)
FI (1) FI934588A0 (cs)
HU (1) HUT70297A (cs)
NO (1) NO933742L (cs)
RU (1) RU2114120C1 (cs)
WO (1) WO1992018154A1 (cs)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE247164T1 (de) 1991-01-08 2003-08-15 Chiron Corp Insulinartigen wachstumsfaktor bindendes protein
US5643867A (en) * 1992-08-26 1997-07-01 Celtrix Pharmaceuticals, Inc. Method for treating catabolic conditions
US5407913A (en) * 1992-12-03 1995-04-18 Celtrix Pharmaceuticals, Inc. Method and composition for systemic treatment of tissue injury
US6124259A (en) * 1993-01-28 2000-09-26 Celtrix Pharmaceuticals, Inc. Method for treating ophthalmic disorders with IGFBP
CA2195474A1 (en) * 1994-07-20 1996-02-01 Cedo Martin Bagi Igf/igfbp complex for promoting bone formation and for regulating bone remodeling
EP0871730B1 (en) 1995-10-11 2004-08-18 Chiron Corporation Combination pdgf, kgf, igf and igfbp for wound healing
ES2344592T3 (es) 2001-01-05 2010-09-01 Pfizer Inc. Anticuerpos frente al receptor del factor de crecimiento similar a la insulina i.
RU2342159C2 (ru) * 2004-07-16 2008-12-27 Пфайзер Продактс Инк. Комбинированная терапия негематологических злокачественных опухолей с использованием анти-igf-1r-антитела
CN108699127A (zh) 2015-12-31 2018-10-23 西门子医疗保健诊断公司 非重组人胰岛素-样生长因子结合蛋白浓缩物
US10212614B2 (en) * 2015-12-31 2019-02-19 Facebook, Inc. Igniting network nodes in a multi-hop wireless network

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7907958A (nl) * 1979-10-30 1981-06-01 Wijn Adriaan Jacques De Kar of onderstel voorzien van opklapbare wielen.
IL68218A (en) * 1983-03-23 1985-12-31 Univ Ramot Compositions for cartilage repair comprising embryonal chondrocytes
EP0289314B1 (en) * 1987-04-28 1994-10-12 Roche Diagnostics GmbH Use of IGF-II in the treatment of bone disorders

Also Published As

Publication number Publication date
KR0129864B1 (en) 1998-04-09
EP0580752A1 (en) 1994-02-02
FI934588A7 (fi) 1993-10-18
JPH06501270A (ja) 1994-02-10
FI934588L (fi) 1993-10-18
JP2527896B2 (ja) 1996-08-28
CA2107475A1 (en) 1992-10-20
AU1784492A (en) 1992-11-17
HUT70297A (en) 1995-09-28
FI934588A0 (fi) 1993-10-18
CZ219093A3 (en) 1994-12-15
RU2114120C1 (ru) 1998-06-27
CZ283601B6 (cs) 1998-05-13
WO1992018154A1 (en) 1992-10-29
HU9302942D0 (en) 1994-01-28
AU658187B2 (en) 1995-04-06
EP0580752A4 (en) 1994-08-24

Similar Documents

Publication Publication Date Title
DK0670729T3 (da) Anvendelse af insulin-lignende vækstfaktorer og analoger til behandling af retinale nervesygdomme
UA42747C2 (uk) Похідні пептиду,фармацевтична композиція та спосіб стимулювання секреції гормону росту
AU1049788A (en) Methods and peptides for the treatment of non-ige-mediated diseases
DE69231486D1 (de) Zusammensetzung enthaltend pdgf und dexamethason zur förderung von gewebsreparatur und -regenerierung
AU6184890A (en) Device for irradiating laser beams
ES2043890T3 (es) Nuevo uso medico.
GR3036188T3 (en) Substituted tetra- and pentapeptide inhibitors of protein:farnesyl transferase
DE3851776D1 (de) Verwendung von IGF-II zur Behandlung von Knochenkrankheiten.
NO953781L (no) Terapeutisk anvendelse av keratinocyttvekstfaktor
AU1955388A (en) Method for potentiating and inhibiting insulin-like growth factor activity
EE9700225A (et) Meetod diabetes mellituse raviks, kasutades KKF
AU3140589A (en) Composition inducing a binding
DK1059934T3 (da) Matrixproteinpræparater til sårheling
FI940375A0 (fi) Peptidit, joilla on elimiä suojaavaa vaikutusta, menetelmä niiden valmistamiseksi ja niiden käyttö terapiassa
AU6682598A (en) Isolation of tissue specific peptide ligands and their use for targeting pharmaceuticals to organs
NO933742L (no) Humant, benavledet, insulinlignende vekstfaktorbindingsprotein
GR3000944T3 (en) Pharmaceutical composition containing thymus extract fractions
ES2187648T3 (es) Metodo para la administracion de farmacos para terapia genica.
EP0339905A3 (en) Wound healing compositions containing growth factors and retinoids
HU9300467D0 (en) Mixture of medical effect containing glutatione and antocithane derivatives
NZ503372A (en) Chemical supplementation of bone by exposing bone to a therapeutic compound and applying a potential difference across the bone or tissue
RU93058185A (ru) Фактор роста, композиция, способ модулирования действий фактора, способ лечения, способ доставки соединения, способы анализа
AU2534595A (en) Angiotensin ii for improving fertilization
EP0588477A3 (en) Medicinal composition comprising tcf-ii
DE3770766D1 (de) Wirkstoffe zur anwendung bei der behandlung von tumoren.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application